Future Directions in Myeloma Post-ASCO

WEBINAR

Future Directions in Myeloma Post-ASCO

Faculty: Noopur Raje, Krina Patel, Nina Shah, Irene Ghobrial

Notification icon This webinar took place on 
http://www.vumedi.com/webinar/future-directions-in-myeloma-post-asco/

Program

Noopur Raje

Professor, Medicine, Harvard Medical School; Director, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, MA

Relapse Refractory Myeloma and Novel Treatments

Krina Patel

Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Clinical Trials in Myeloma

Nina Shah

Associate Professor, Department of Medicine, UCSF, San Francisco, CA

The Future of CAR T Therapies in Myeloma

Irene Ghobrial

Director, Michele & Steven Kirsch Laboratory
Director, Clinical Investigator Research Program
Senior Physician
Associate Professor of Medicine, Harvard Medical School

Smoldering Myeloma

Faculty:

  • Noopur Raje

    Professor, Medicine, Harvard Medical School; Director, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, MA

  • Krina Patel

    Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Nina Shah

    Associate Professor, Department of Medicine, UCSF, San Francisco, CA

  • Irene Ghobrial

    Director, Michele & Steven Kirsch Laboratory Director, Clinical Investigator Research Program Senior Physician Associate Professor of Medicine, Harvard Medical School

Release: 06/18/2018

Expiration: 06/25/2018

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Oncology.

Course Description: In this live webinar, expert Breast, Central Nervous System, Gastrointestinal, Genitourinary, Gynecologic, Head & Neck, Hematologic, Lung, Sarcoma, Skin, MPN will present optimal operable techniques and treatment options to address Future Directions in Myeloma Post-ASCO. The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

  1. Relapse Refractory Myeloma and novel treatments
  2. Clinical trials in Myeloma
  3. The future of CAR T therapies in Myeloma
  4. Smoldering Myeloma

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, Irvine School of Medicine and VuMedi. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement: The University of California, Irvine School of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures:
Dr. Krina Patel discloses the following relevant financial relationships with a commercial interest: Celgene, Hikma Pharmaceuticals, Amgen: Advisor or Review Panel Member; Takeda: Grants/Research Support,Advisor or Review Panel Member; Poseida: Grants/Research Support.
Dr. Nina Shah discloses the following relevant financial relationships with a commercial interest: Celgene, Bluebird, Janssen: Grants/Research Support; Teneobio, Takeda: Advisor or Review Panel Member
Dr. Noopur Raje discloses the following relevant financial relationships with a commercial interest: Amgen, Celgene, Millennium, and Onyx: Consultant.
Dr. Irene Ghobrial discloses the following relevant financial relationships with a commercial interest: Amgen Inc., Celgene Corporation, Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals, Inc., Takeda Pharmaceuticals North America, Inc.: Advisor or Review Panel Member, Consultant; Celgene Corporation, Novartis Pharmaceuticals Corporation, Takeda Pharmaceuticals North America, Inc.: Grants/Research Support.


Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: Ellen P. Seaback, CMP, CAE, CHCP
Executive Director
Office of Continuing Medical Education
UC Irvine Health School of Medicine
Irvine, California
eseaback@uci.edu
949.824.1150
http://www.meded.uci.edu/CME/

For questions regarding this activity, please contact VuMedi: cme@vumedi.com


0 Comments
Login to view comments. Click here to Login